FDA and State Boards Eye GLP-1s Amid Larger Compounding Scrutiny - Pharmacy Practice News
Dae Y. Lee, Pharm.D., Esq., CPBS, shareholder in the firm's FDA section, was featured in an Pharmacy Practice News article entitled "FDA and State Boards Eye GLP-1s Amid Larger Compounding Scrutiny."
Contributors